Matrix metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment

MLA

Patrick Henriet, et al. Matrix Metalloproteinase Activity Correlates with Uterine Myoma Volume Reduction after Ulipristal Acetate Treatment. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....db54b288f211b5f8af87740e149e3904&authtype=sso&custid=ns315887.

APA

Patrick Henriet, Etienne Marbaix, Guillaume E. Courtoy, Matthieu de Codt, Jacques Donnez, Marie-Madeleine Dolmans, & Mathieu Luyckx. (2018). Matrix metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment.

Chicago

Patrick Henriet, Etienne Marbaix, Guillaume E. Courtoy, Matthieu de Codt, Jacques Donnez, Marie-Madeleine Dolmans, and Mathieu Luyckx. 2018. “Matrix Metalloproteinase Activity Correlates with Uterine Myoma Volume Reduction after Ulipristal Acetate Treatment,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....db54b288f211b5f8af87740e149e3904&authtype=sso&custid=ns315887.